Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Effectiveness of Chemoradiotherapy for Metachronous Esophageal Squamous Cell Carcinoma ; volume:102 ; number:4 ; year:2021 ; pages:622-629 ; extent:8
Digestion ; 102, Heft 4 (2021), 622-629 (gesamt 8)
- Urheber
-
Suzuki, Yugo
Kikuchi, Daisuke
Hoteya, Shu
Okamura, Takayuki
Ochiai, Yorinari
Hayasaka, Junnosuke
Dan, Nobuhiro
Mitsunaga, Yutaka
Tanaka, Masami
Odagiri, Hiroyuki
Nomura, Kosuke
Yamashita, Satoshi
Matsui, Akira
Iizuka, Toshiro
- DOI
-
10.1159/000510368
- URN
-
urn:nbn:de:101:1-2021072200321138892224
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Suzuki, Yugo
- Kikuchi, Daisuke
- Hoteya, Shu
- Okamura, Takayuki
- Ochiai, Yorinari
- Hayasaka, Junnosuke
- Dan, Nobuhiro
- Mitsunaga, Yutaka
- Tanaka, Masami
- Odagiri, Hiroyuki
- Nomura, Kosuke
- Yamashita, Satoshi
- Matsui, Akira
- Iizuka, Toshiro
Ähnliche Objekte (12)
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Esophageal squamous papilloma
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy
Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Esophageal squamous papilloma
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy
Prognostic factors for salvage endoscopic resection for esophageal squamous cell carcinoma after chemoradiotherapy or radiotherapy alone
Predictors of pathological complete response to neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Involved-field irradiation in definitive chemoradiotherapy for locally advanced esophageal squamous cell carcinoma
Neoadjuvant vs definitive concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma patients
Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma
Esophageal squamous papilloma
Murine double minute 2 predicts response of advanced esophageal squamous cell carcinoma to definitive chemoradiotherapy
Multimodality deep learning radiomics predicts pathological response after neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma
Adjuvant chemotherapy does not benefit patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma
Esophageal squamous cell carcinoma with EP300 mutations displays distinct genetic characteristics relevant to neoadjuvant chemoradiotherapy